ACT Brief: APAC Sponsor Priorities, Continuous Glucose Monitoring Trials, and GLP-1 Eye Warning

0:00-1:52

In today’s ACT Brief, we examine three priorities for first-time APAC sponsors, how continuous glucose monitoring should be used in diabetes trials, and why FDA is requiring a new eye-related warning across GLP-1 medications.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8975859

Published

November 12, 2026

Duration

2 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#apacsponsorpriorities #continuousglucosemonitoring #eyewarning #lifesciences

The Nile